🔗 Visit the ClinicalTrials.gov page for NCT00758498
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder. | Mayo Clin Proc | 2010 | 0.82 |
| 2 | Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function. | Hum Psychopharmacol | 2009 | 0.79 |